CCK-8 (Human) [1702]
CCK-8 (Human)
| SMILES | CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |
| InChIKey | IZTQOLKUZKXIRV-YRVFCXMDSA-N |
| Sequence | DYMGWMDF |
| HELM | PEPTIDE1{D.[X96].M.G.W.M.D.F.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 13 |
| Rotatable bonds | 33 |
| Log P | -1.329 |
| Molecular weight (Da) | 1142.4 |
| Stereochemistry info | unspecified |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
CCK-8 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0